Cardiorenal outcomes in eligible patients referred for bariatric surgery

Satya Dash1,2,3, Karl Everett4, Timothy Jackson3,5

  • 1Division of Endocrinology, University Health Network, Toronto, Ontario, Canada.

Insights

Bariatric surgery significantly reduces cardiovascular disease (CVD) and heart failure hospitalizations, even in patients without type 2 diabetes (T2D). However, non-progression to surgery is linked to increased CVD risk, highlighting the need for further trials.

Area of Science:

  • Cardiology
  • Metabolic Surgery
  • Nephrology

Background:

  • Bariatric surgery is known to reduce cardiovascular disease (CVD) and heart failure hospitalizations in patients with type 2 diabetes (T2D) and pre-existing CVD.
  • However, most patients undergoing bariatric surgery do not have T2D or CVD, and their clinical outcomes are less established.
  • Many eligible patients opt out of surgery due to self-exclusion, despite potential benefits.

Purpose of the Study:

  • To assess the cardiorenal outcomes of bariatric surgery in a broad patient population, including those without T2D or prior CVD.
  • To investigate the association between non-progression to surgery and subsequent cardiovascular events.

Main Methods:

  • Retrospective analysis of cardiorenal outcomes in 8,568 patients referred for bariatric surgery.
  • Multivariate adjustment was used to control for various demographic and clinical factors.
  • Comparison of outcomes between patients who underwent surgery and those who did not.

Main Results:

  • Patients undergoing bariatric surgery showed significantly lower risks of primary (HR=0.52) and secondary (HR=0.53) CVD outcomes compared to those who did not.
  • These benefits were observed in both patients with (HR=0.45-0.47) and without (HR=0.53-0.61) T2D.
  • Surgery was associated with reduced kidney disease hospitalization (HR=0.46) but increased liver disease hospitalization (HR=2.5).

Conclusions:

  • Non-progression to bariatric surgery is associated with an increased risk of CVD, even in patients with a low baseline prevalence of CVD.
  • The cardiorenal benefits of bariatric surgery observed in this study warrant confirmation through a well-powered randomized clinical trial.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
54
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
568
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
261
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
95
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
528
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.2K